| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | - CEO | TWSE Exchange | TW0004111000 ISIN |
| Taiwan Country | - Employees | 25 Aug 2026 Last Dividend | 17 Sep 2015 Last Split | - IPO Date |
Chi Sheng Pharma & Biotech Co., Ltd, founded in 1962 and based in Hsinchu, Taiwan, operates in the healthcare sector with a focus on the development, manufacturing, and distribution of pharmaceuticals, medical products, and other related health and well-being items. The company boasts a broad international and domestic presence, catering to the needs of various stakeholders through its vast range of products. Chi Sheng’s operations encompass the processing, sale, and both import and export trade, underlining its comprehensive approach to serving the healthcare industry. Its product lineup is designed to address a wide array of health conditions and requirements, stretching from essential vitamins to sophisticated medical equipment.
Chi Sheng Pharma & Biotech Co., Ltd offers a diverse portfolio of products and services across several health-related categories: